Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight Loss with Orlistat or Sibutramine in PCOS
NCT01475019Phase 4Unknown
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2004
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of orlistat, sibutramine in polycystic ovary syndrome (PCOS), obesity, sponsored by Aristotle University of Thessaloniki. Status: unknown.
02
Drugs
orlistatsibutramine
03
Conditions
polycystic ovary syndrome (PCOS)obesity
Beyond the preview
Go deeper on NCT01475019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475019.